TheDose

Sodium Pca

Also known as Sodium Pyrrolidone Carboxylate, Sodium Pyroglutamate, NaPCA, Sodium 2-Pyrrolidone-5-Carboxylate

CIRPubMed

Safe

CIR Expert Panel says: safe as used in cosmetics.”

The CIR Expert Panel (2019) confirmed that PCA and its salts, including Sodium PCA, are safe in cosmetics at present practices of use and concentration, with the qualification that they should not be used in products where N-nitroso compounds can form. Sodium PCA is a component of the skin's natural moisturizing factor (NMF) and has been shown to function as an effective humectant at concentrations of at least 2% in appropriate vehicles. It is nonirritating and nonsensitizing in clinical testing up to 50% concentration.


Component of the skin's natural moisturizing factor (NMF)

Effective humectant — attracts and retains moisture in the stratum corneum

Nonirritating and nonsensitizing at cosmetic use concentrations

Assists in restoring ordered lipid bilayer structure in skin


Concerns
  • · Should not be incorporated into formulations where N-nitroso compound formation is possible

CIR Expert Panel
Approved
should not be used in cosmetic products in which N-nitroso compounds can be formed
[1]
CIR Expert Panel · Jul 1, 2018Live

CIR Quick Reference Table (12/2017, revised 07/2018) — SODIUM PCA row: Finding=SQ, Citation=IJT 18(S2):25-34, 1999; Final report 12/2014 …

Sodium PCA SQ safe as used; should not be used in cosmetic products in which N-nitroso compounds can be formed IJT 18(S2):25-34, 1999; Final report 12/2014 available from CIRQRT-122017revised072018.pdf, p. 122
Verificationpdf_textView source
[2]
Peer-reviewed (PubMed) · Sep 1, 2019

Safety Assessment of PCA (2-Pyrrolidone-5-Carboxylic Acid) and Its Salts as Used in Cosmetics

Verificationweb_textView on PubMed
[3]
Peer-reviewed (PubMed) · Jun 1, 1981

Pyrrolidone carboxylic acid and the skin

Verificationweb_textView on PubMed
[4]
Peer-reviewed (PubMed) · Jan 1, 1995

Direct or indirect skin lipid-ordering effect of pyrrolidone carboxylate sodium after topical treatment with penetration enhancers

Verificationweb_textView on PubMed
Sources
4
PubMed citations
3
Evidence quality
moderate
Last verified
Re-reviewed when a new CIR / SCCS opinion publishes.